Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Autologous Serum Eye Drops in Dry Eye Disease
NCT07407101Completed
- Sponsor
- CHU de Limoges
- Start
- Apr 2026
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Limoges. Primary endpoint: Differences in concentrations of active molecules. Started Apr 2026; status: completed.
Beyond the preview
Go deeper on NCT07407101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07407101.